Last updated: June 25, 2026
Suppliers for PRISMASOL BGK 4/2.5 in Plastic Container: Who Manufactures, Sources, and Distributes
PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER is a dialysis replacement fluid product used in continuous renal replacement therapy (CRRT). Supplier coverage typically breaks into (1) the manufacturing platform and regulatory labeler, (2) commercial distributors by country and tender lane, and (3) pharmacy channel wholesalers for hospital procurement.
No verifiable supplier list can be produced from the information provided. Without the country/market, package label language, NDC/marketing authorization holder, or the exact manufacturer name printed on the specific carton and blister/label, any “supplier” mapping would be speculative.
Which company supplies PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER for hospitals?
Featured-snippet answer: In most EU markets, the product is supplied under a marketing authorization by a specific “authorized distributor/MAH” and stocked through hospital procurement channels. The precise supplier depends on the national product registration and the labeler on the specific packaging.
What supplier roles exist for CRRT replacement fluids
- Manufacturing site (batch manufacturing and filling of plastic containers).
- Marketing authorization holder / labeler (regulatory responsibility for the marketed product).
- Distributor (tender fulfillment and logistics into hospital accounts).
- Wholesaler (pharmacy and hospital stock routing).
How to identify the correct supplier on the carton
- “Marketing authorization holder” or “manufacturer” line on the outer carton.
- Batch/lot label.
- Country-specific leaflet imprinting distributor/MAH name.
What is the manufacturer and MAH (marketing authorization holder) of PRISMASOL BGK 4/2.5 in plastic container?
Featured-snippet answer: The manufacturer/MAH is printed on the product label and varies by registration market.
What to extract from the labeling to build a supplier map
- Brand strength and description (BGK 4/2.5).
- Container type (plastic container).
- Registration country.
- Manufacturer name and address.
- MAH name and address.
- EU or national marketing authorization number (if present).
Who distributes PRISMASOL BGK 4/2.5 plastic container in the US or EU?
Featured-snippet answer: Distribution depends on market authorization and tender networks, with different wholesalers and distributors per geography.
Key distribution channels used for hospital CRRT products
- GPO-negotiated hospital contracts (where applicable).
- Tender-driven national supply contracts.
- Direct-to-hospital distribution from authorized wholesalers.
What suppliers provide PRISMASOL BGK 4/2.5 for hospital tenders and pharmacy stocking?
Featured-snippet answer: Hospital tenders are typically won by authorized distributors or wholesalers in that jurisdiction; these listings are tied to the product’s national tender code and registration.
How tender listings usually map to suppliers
- Wholesaler appears on the bid as supplier of record.
- MAH/manufacturer remains the upstream regulated entity.
- Storage and logistics may sit with a distributor even if manufacturing is offshore.
How strong is the supplier ecosystem for PRISMASOL BGK 4/2.5 (risk of shortages)?
Featured-snippet answer: For CRRT fluids, supply risk is shaped by container manufacturing capacity, regulatory release throughput, and single-site dependence by market authorization.
Supply risk drivers commonly seen in CRRT consumables
- Limited container manufacturing suppliers.
- Batch release bottlenecks tied to local compliance testing.
- Contract allocation during hospital budgeting cycles.
What alternative CRRT replacement fluids can be sourced if PRISMASOL BGK 4/2.5 is constrained?
Featured-snippet answer: Substitutable products are usually other bicarbonate-based, potassium-calcium balanced CRRT replacement fluids with comparable electrolyte composition and indicated use for the specific CRRT modality.
What “BGK 4/2.5” implies for comparability
- “BGK” indicates buffered electrolyte composition used for CRRT replacement.
- “4/2.5” refers to potassium/calcium levels (composition match is required for substitution).
What regulatory status determines who can legally supply PRISMASOL BGK 4/2.5?
Featured-snippet answer: Only products registered in the target market and supplied through authorized channels can be legally distributed for hospital use.
Regulatory gates that define eligible suppliers
- Market authorization (EMA/National).
- Batch release rules (national import control and QA release).
- Authorized distribution permissions for that product.
Key Takeaways
- Supplier identification for PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER requires the specific market and the label-printed manufacturer/MAH/distributor from the carton or leaflet.
- “Suppliers” in CRRT consumables split into manufacturer, MAH/labeler, and hospital-facing distributors/wholesalers; each is different by geography and tender lane.
- With only the product name and container description, a definitive supplier list cannot be produced without risking inaccuracies.
FAQs
- What is the NDC or marketing authorization number for PRISMASOL BGK 4/2.5 in plastic container?
- Does PRISMASOL BGK 4/2.5 come from one manufacturing site or multiple sites by region?
- Which distributors typically supply CRRT replacement fluids to hospitals under tender contracts?
- Are CRRT replacement fluids with different container sizes or bag types interchangeable with PRISMASOL BGK 4/2.5?
- How do hospital substitution rules treat electrolyte-composition matched CRRT fluids when PRISMASOL is unavailable?
References
- (No sources cited because no verifiable supplier/manufacturer details were provided in the input.)
